Skip to main navigation Skip to search Skip to main content

A Phase 3 Radomized, Double-Blind, Placebo-Controlled, MultiCenter Study to Assess the Efficacy and Safety of Lumateperone Monotherapy in the Treatment of Patients with Major Depressive Epidosdes Associated with Bipolar I or Bipolar II (Bip

Project: Research

Project Details

StatusFinished
Effective start/end date05/8/18 → 05/8/21

Funding

  • Intra Cellular Therapies Incorporated: $19,172.00